IncFact
Company Profiles: Revenue, Growth, Competition

Outlook Therapeutics Revenue, Growth & Competitor Profile

DBA ONCOBIOLOGICS INC
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Outlook Therapeutics

Access the complete profile.

Outlook Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
325414 Biological Product Manufacturing
Address485 Route 1 South Building F, Suite 320
Iselin, NJ 08830

oncobiologics.com
Note: Revenues for privately held companies are statistical evaluations.


Outlook Therapeutics's annual revenues are $1 - $10 million (see exact revenue data) and has 1 - 10 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Outlook Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Outlook Therapeutics Annual Revenue and Growth Rate

Outlook Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $1 - $10 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Outlook Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Outlook Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
April 16, 2024 1 38%$13 MM
Complete list of funding rounds and total amounts in the Company Report




Outlook Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Outlook Therapeutics Revenue (Sales) Outlook Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Outlook Therapeutics is developing and marketing. Outlook Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
LYTENAVA
Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease
09/14/2023
LYTENAVA NAVIGATOR
Printed publications in the nature of brochures, pamphlets, and newsletters in the field of medical information and patient support
03/09/2023

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Outlook Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Outlook Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Outlook Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Outlook Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Outlook Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
SANOFI-AVENTIS PUERTO RICOBridgewater, NJ100 
AMNEAL PHARMACEUTICALS OF NEW YORKBridgewater, NJ17 
TRIS PHARMAMonmouth Junction, NJ3 
BAUSCH HEALTH USBridgewater, NJ3 
LEGEND BIOTECH USASomerset, NJ3 
BRACCO DIAGNOSTICSMonroe Township, NJ2 




Future Competition: Outlook Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Outlook Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Outlook Therapeutics Competitors